Healthcare

Key data points: The market size in 2030 = $1.4 billion, growth forecast = 7.5% annually for the next 6 years. Scroll below to get more insights. This market report covers trends, opportunities, and forecasts in the global adenovirus vaccine market to 2030 by type (type 4 vaccine and type 7 vaccine), application (research and academic, laboratories, and pharmaceutical & biotechnology), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The market size in 2030 = $8.9 billion, growth forecast = 8.0% annually for the next 6 years. Scroll below to get more insights. This market report covers trends, opportunities, and forecasts in the global liposomes for drug delivery market to 2030 by type (liposome vitamin, liposome ceramide, liposome coq10, and others), application (hydrophilic drugs and hydrophobic drugs), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The market size in 2030 = $18.7 billion, growth forecast = 7.7% annually for the next 6 years. Scroll below to get more insights. This market report covers trends, opportunities, and forecasts in the global implantable drug delivery device market to 2030 by product (contraceptive implants, spinal implants, brachytherapy seeds, drug-eluting stents, bio-absorbable stents, intraocular stents, infusion pumps, and others), type (biodegradable and non-biodegradable), technology (diffusion, osmotic, magnetic, and others), application (contraception, ophthalmology, cardiovascular, diabetes, oncology, autoimmune diseases, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The market size in 2030 = $11.2 billion, growth forecast = 6.8% annually for the next 6 years. Scroll below to get more insights. This market report covers trends, opportunities, and forecasts in the global hydrogel-based drug delivery system market to 2030 by polymer origin (natural, synthetic, and hybrid), route (subcutaneous, ocular, oral cavity, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The market size in 2030 = $24.7 billion, growth forecast = 8.2% annually for the next 6 years. Scroll below to get more insights. This market report covers trends, opportunities, and forecasts in the global drug discount card market to 2030 by type (branded cards and generic cards), sales channel (online and offline), therapeutic category (cardiovascular drug, diabetes drug, pain medication, mental health medication, cancer drug, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The growth forecast = 5.5% annually for the next 6 years. Scroll below to get more insights. This market report covers trends, opportunities, and forecasts in the global starch softgel capsules market to 2030 by distribution channel (supermarket and hypermarket, pharmacy and drugstore, and online provider), application (health supplements, pharmaceutical, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The market size in 2030 = $7.6 billion, growth forecast = 3.5% annually for the next 6 years. Scroll below to get more insights. This market report covers trends, opportunities, and forecasts in the global drug of abuse testing service market to 2030 by drug type (alcohol, cannabis/marijuana, cocaine, opioids, amphetamine & methamphetamine, LSD, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The market size in 2030 = $11.2 billion, growth forecast = 4.8% annually for the next 6 years. Scroll below to get more insights. This market report covers trends, opportunities, and forecasts in the global pneumococcal vaccine market to 2030 by product type (prevnar 13, synflorix, and pneumovax23), vaccine type (pneumococcal conjugate vaccine and pneumococcal polysaccharide vaccine), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The market size in 2030 = $6.7 billion, growth forecast = 8.5% annually for the next 6 years. Scroll below to get more insights. This market report covers trends, opportunities, and forecasts in the global meningococcal vaccine market to 2030 by type (polysaccharide, conjugate vaccines, combination vaccines, men B vaccines, and others), end use (retail pharmacies, hospital pharmacies, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The growth forecast = 5.8% annually for the next 6 years. Scroll below to get more insights. This market report covers trends, opportunities, and forecasts in the global measles vaccine market to 2030 by type (mumps measles rubella vaccine and live mmr-II), application (pediatric population, adolescent population, and adult population), end use (hospitals, vaccination centers, and community clinics), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The market size in 2030 = $17.9 billion, growth forecast = 10.1% annually for the next 6 years. Scroll below to get more insights. This market report covers trends, opportunities, and forecasts in the global rotavirus vaccine market to 2030 by type (rotarix, rotateq, rotavin-m1, lanzhou lamb, and others), end use (hospitals and clinics, academic and research, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The growth forecast = 2.8% annually for the next 6 years. Scroll below to get more insights. This market report covers trends, opportunities, and forecasts in the global gaucher disease drug market to 2030 by type (type 1, type 2, type 3, and others), therapy (enzyme replacement therapy, substrate replacement therapy, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The market size in 2030 = $9.1 billion, growth forecast = 5.6% annually for the next 6 years. Scroll below to get more insights. This market report covers trends, opportunities, and forecasts in the global pertussis vaccine market to 2030 by type (Dtap vaccine and Tdap vaccine), end use (vaccination centers, hospitals, clinics, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The market size in 2030 = $30.8 billion, growth forecast = 5.7% annually for the next 6 years. Scroll below to get more insights. This market report covers trends, opportunities, and forecasts in the global pediatric vaccine market to 2030 by vaccine type (monovalent and multivalent), technology (live attenuated, inactivated, subunit, toxoid, conjugate, and others), application (infectious disease, cancer, allergy, pneumococcal disease, influenza, measles, mumps, and rubella (MMR)​, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The market size in 2030 = $1.0 billion, growth forecast = 3.6% annually for the next 6 years. Scroll below to get more insights. This market report covers trends, opportunities, and forecasts in the global hepatitis a vaccine market to 2030 by type (inactivated vaccine and live attenuated vaccine), application (government institution, private sector, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The market size in 2030 = $7.5 billion, growth forecast = 6.5% annually for the next 6 years. Scroll below to get more insights. This market report covers trends, opportunities, and forecasts in the global diphtheria vaccine market to 2030 by vaccine type (DTaP vaccine, DT vaccine, Tdap vaccine, and Td vaccine), end use (hospitals, clinics, vaccination centers, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The market size in 2030 = $24.4 billion, growth forecast = 6.1% annually for the next 6 years. Scroll below to get more insights. This market report covers trends, opportunities, and forecasts in the global adult vaccine market to 2030 by technology (live attenuated, inactivated, subunit, toxoid, conjugate, and others), vaccine type (monovalent and multivalent), end use (private healthcare firms and government hospitals), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The market size in 2030 = $1.3 billion, growth forecast = 5.8% annually for the next 6 years. Scroll below to get more insights. This market report covers trends, opportunities, and forecasts in the global glioblastoma treatment drug market to 2030 by drug class (antineoplastic, VEGF/VEGFR inhibitors, alkylating agents, and miscellaneous antineoplastic), distribution channel (hospitals, cancer research organizations, long term care centers, diagnostic centers, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Trends, opportunity and forecast in antifibrinolytic drug market to 2030 by indication (gynecology, hereditary angiedema, fibrinolytic response testing, surgeries, and others), end use (hospitals & clinics, ambulatory surgical centers, and trauma centers), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Trends, opportunity and forecast in aneurysmal subarachnoid hemorrhage drug market to 2030 by drug class (calcium channel blocker, anticonvulsant, stool softener, osmotic agents/diuretics, opioid analgesic, and others) and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The market size in 2030 = $0.8 billion, growth forecast = 6.5% annually next 6 years. Scroll below to get more insights. This market report covers trends, opportunities, and forecast in the global DNA vaccine market to 2030 by product type (oncept, west nile-innovator, and apex-IHN), type (therapeutic vaccines and prophylactic vaccines), end use (veterinary clinics and veterinary hospitals), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The market size in 2030 = $0.7 billion, growth forecast = 7.6% annually next 6 years. Scroll below to get more insights. This market report covers trends, opportunities, and forecast in the global aquaculture vaccine market to 2030 by product (inactivated vaccines and DNA vaccines), route of administration (injected and oral), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Trends, opportunity and forecast in tramadol drug market to 2030 by type (tablet, capsule, liquid, suspension, and others), application (clinic and hospitals), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Trends, opportunity and forecast in compound glycyrrhizin tablet market to 2030 by type (white film-coated tablets and white sugar-coated tablets), application (hospital, clinic, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Trends, opportunity and forecast in catecholamine market to 2030 by type (epinephrine, norepinephrine, and dopamine), route of administration (intravenous, inhalation, transdermal, and others), indication (anaphylaxis, cardiac arrest, shock, acute asthma, hypertension, and other indications), distribution channel (hospital pharmacy, retail pharmacy, and online pharmacy), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Trends, opportunity and forecast in cancer cachexia market to 2030 by mode of action (appetite stimulators, weight loss stabilizers, and others), drugs (progestogens, corticosteroids, combination therapies, and others), distribution channel (hospital stores, retail pharmacy, and online pharmacy), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Trends, opportunity and forecast in lipid injectable market to 2030 by product type (smoflipid and clinolipid), application (pain reduction, toxicity reduction, targeted drug delivery, and others), end use (hospitals, specialty clinics, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Trends, opportunity and forecast in injectable potassium phosphate market to 2030 by doses forms (5 ml, 15 ml, and 50 ml), route of administration (peripheral venous catheters and central venous catheters), end use (hospitals, clinics, ambulatory surgery centers, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Trends, opportunity and forecast in injectable cement market to 2030 by type (high viscosity cement, low viscosity cement, and medium viscosity cement), application (spine fusion, bone fracture, and others), end use (hospital, clinics, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Trends, opportunity and forecast in brain tumor drug market to 2030 by therapy (targeted therapy, chemotherapy, immunotherapy, and others), indication (pituitary, meningioma, glioma, and others), distribution channel (hospital pharmacy and retail & online pharmacy), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Trends, opportunity and forecast in cholesterol-lowering drug market to 2030 by disease type (cardiovascular diseases, hypercholesterolemia, and hyperlipidemia), class of drug (cholesterol absorption inhibitors, fibrates, fixed-dose combinations, ion exchange resins, novel cholesterol-lowering drugs, PCSK9 inhibitors, and statins), distribution channels (hospital pharmacies, online pharmacies, and retail pharmacies), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Trends, opportunity and forecast in RNAi drug delivery market to 2030 by technology (nanoparticle drug delivery, pulmonary drug delivery, nucleic acid drug delivery, and aptamer drug delivery), application (infectious disease, cardiology, oncology, neurology, ophthalmology, urology, metabolic disorders, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Trends, opportunity and forecast in asthma and COPD drugs market to 2030 by diseases (asthma and COPD), medication class (combination drugs, short acting beta agonists, long acting beta agonists, leukotriene antagonists, anticholinergics, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Trends, opportunity and forecast in rosacea treatment market to 2030 by drug class (antibiotics, alpha agonists, retinoids,corticosteroids, immunosuppressants, antihypertensive agents, and others), mode of administration (topical and oral), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Trends, opportunity and forecast in swine vaccine market to 2030 by product (recombinant and inactivated), disease type (classical swine fever, porcine parvovirus, swine influenza, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Trends, opportunity and forecast in subunit vaccine market to 2030 by product type (protein antigen and polysaccharide antigen), disease (infectious disease, diphtheria, tetanus and pertussis (DTP), HPV, measles, mumps and rubella (MMR), and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Trends, opportunity and forecast in poultry vaccine market to 2030 by product (attenuated live vaccines, inactivated vaccines, and recombinant vaccines), disease type (bronchitis, avian influenza, newcastle disease, Marek's disease, and others), application (broiler, layer, and breeder), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Trends, opportunity and forecast in thyroid eye disease market to 2030 by treatment type (corticosteroids, vitamins, and monoclonal antibody), route of administration (oral, topical, and parenteral), product (tablet, capsule, ointment, and solution), end use industry (hospitals, and clinics), and region (North America, Europe, Asia Pacific, and the Rest of the World).

Trends, opportunity and forecast in the global antibody immunohistochemistry market to 2028 by product type (monoclonal antibody and polyclonal antibody), application (diagnostics, cancer, infectious, nephrological diseases, autoimmune diseases, neurological diseases, research, and others), end use (hospitals, diagnostic laboratories, academic institutes, and others), and region

Trends, opportunity and forecast in the global brain health supplement market to 2028 by product (natural molecules, herbal extract, and vitamins & minerals), application (memory enhancement, attention & focus, depression & mood, sleep and recovery, anti-aging & longevity, and stress & anxiety), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Trends, opportunities, and forecast for the global overactive bladder treatment market from 2017 to 2028 by product type (anticholinergics, mirabegron, botox, neuromodulation, and others), disease type (idiopathic overactive bladder and neurogenic overactive bladder), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Trends, opportunities, and forecast for the global enteral feeding formula market from 2017 to 2028 by product (standard formula, disease specific, diabetic formulas, renal formulas, hepatic formula, pulmonary formulas, and other formulas), stage (adults and pediatric), application (oncology, gastrointestinal diseases, and other applications), end use industry (hospitals, long term care facilities, nursing homes, assisted living facilities, and home care agencies & hospices), and region

Trends, opportunities, and forecast for the global high potency API market from 2017 to 2028 by type (innovative API market and generic API market), type of synthesis (synthetic API market and biotech API market), type of manufacturers (captive API market and merchant API market), therapeutic application (oncology, hormonal imbalance, glaucoma, and other therapeutic applications) and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Trends, opportunities, and forecast for the global pharmaceutical gelatin market from 2017 to 2028 by type (type A and type B), function (stabilizing agent, thickening agent, and gelling agent & other function), source (porcine, bovine skin, bovine bones, marine, and poultry), application (hard capsules, softgel capsules, tablets, absorbable hemostats, and other applications), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Trends, opportunities, and forecast for the global prostate health market from 2017 to 2028 by disease indication (prostate cancer, prostatitis, alpha blockers, benign prostate hyperplasia, and others), treatment outlook (cytotoxic agents, hormone ADT, AR directed therapies, PARP inhibitors, and others), and distribution channel (pharmacy, e-commerce stores, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Trends, opportunity and forecast in the global animal parasiticide market to 2028 by product type (ectoparasiticides, endoparasiticides, and endectocides), animal type (companion animals and livestock animals), end use industry (veterinary clinics & hospitals, animal farms, and home care settings), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Trends, opportunity and forecast in the global vaccine adjuvant market to 2028 by product (pathogen, adjuvant emulsion, particulate, and combination), application (infectious diseases and cancer), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Trends, opportunity and forecast in the global recombinant protein market to 2028 by product type (hormones, growth factors, enzymes, antibodies, and others), expression system (microbes, plants, and animals), application (research, therapeutics, biotechnology, disease diagnostics, and others), end use industry (pharma & biotechnology companies, academic & research institutes, diagnostic laboratories, and others), and region

Trends, opportunities, and forecast for the global empty capsule market from 2017 to 2028 by product type (gelatin capsules and non-gelatin capsules), functionality (immediate-release capsules, sustained-release capsules, and delayed-release capsules), therapeutic application (antibiotic & antibacterial drugs, dietary supplements, antacid & antiflatulent preparations, and others), end use industry (pharmaceutical industry, nutraceutical industry, and others), and region

Trends, opportunities, and forecast for the global cell therapy technology market from 2017 to 2028 by product (media, sera, and reagents, cell engineering products, cell culture vessels, cell therapy equipment, and others), process (cell processing, cell preservation, distribution and handling, and process monitoring and quality control), cell type (T-cell, stem cell, and others), end use industry (biopharmaceutical and biotechnology companies, and others), and region